JO
VCNX

John Overdeck’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

John Overdeck’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,154
Closed -$10.7K – 3453
2023
Q4 		$10.7K Buy
+1,154
New +$13.6K ﹤0.01% 3082

Other funds holding VCNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

John Overdeck's VCNX Position: Q1 2024 in Review

John Overdeck sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 1,154 shares — an estimated $10.7K sold.

John Overdeck first reported a position in VCNX in Q4 2023 and held it in 1 quarter. The position peaked at $10.7K in Q4 2023. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

  • John Overdeck reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • John Overdeck sold 1,154 Vaccinex, Inc. Common Stock shares in Q1 2024, an estimated $10.7K.
  • John Overdeck first reported a position in Vaccinex, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • John Overdeck's Vaccinex, Inc. Common Stock position peaked at $10.7K in Q4 2023.
  • 12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.